Capstone Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$230K Sell
5,540
-670
-11% -$25.5K 0.01% 1438
2017
Q1
$219K Sell
6,210
-1,710
-22% -$54.1K 0.01% 1488
2016
Q4
$244K Sell
7,920
-7,560
-49% -$234K 0.01% 1448
2016
Q3
$467K Sell
15,480
-350
-2% -$10.6K 0.01% 1005
2016
Q2
$433K Buy
15,830
+2,230
+16% +$57K 0.01% 1035
2016
Q1
$365K Sell
13,600
-440
-3% -$10.8K 0.01% 1132
2015
Q4
$397K Sell
14,040
-1,600
-10% -$46.1K 0.01% 1078
2015
Q3
$436K Buy
15,640
+820
+6% +$29.6K 0.01% 1003
2015
Q2
$612K Sell
14,820
-8,530
-37% -$312K 0.02% 826
2015
Q1
$709K Buy
23,350
+560
+2% +$14.5K 0.02% 856
2014
Q4
$451K Sell
22,790
-11,390
-33% -$255K 0.01% 1113
2014
Q3
$681K Buy
34,180
+920
+3% +$19.4K 0.02% 807
2014
Q2
$758K Buy
+33,260
New +$592K 0.02% 769

Other funds holding RGEN

Capstone Asset Management's RGEN Position: Q2 2017 in Review

Capstone Asset Management reduced its Repligen (RGEN) stake by 11% in Q2 2017, selling an estimated $25.5K and leaving 5,540 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #1438.

Capstone Asset Management first reported a position in RGEN in Q2 2014 and has held it in 13 quarters since. The position peaked at $758K in Q2 2014. 199 funds tracked by Wall St. Rank hold RGEN as of Q2 2017.

  • Capstone Asset Management held 5,540 shares of Repligen worth $230K as of Q2 2017.
  • Capstone Asset Management sold 670 Repligen shares in Q2 2017, an estimated $25.5K.
  • Repligen made up 0.01% of Capstone Asset Management's portfolio in Q2 2017, its #1438 holding.
  • Capstone Asset Management first reported a position in Repligen in Q2 2014 and has held it in 13 quarters since.
  • Capstone Asset Management's Repligen position peaked at $758K in Q2 2014.
  • 199 funds tracked by Wall St. Rank held Repligen as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.